Strikingly, none of the mice injected with basal or luminal Neu+/−Rank+/tg MECs developed tumors six months after the injection (Fig. 3a), indicating that Rank overexpression drastically diminishes the tumor forming ability of luminal and basal MECs derived from the Neu+/− background. The gene discussed is TNFRSF11A; the disease is neoplasm.